This study demonstrated, for the first time, that immunity genes licFGEHI are not essential for selfprotection and production of the two-component lantibiotic lichenicidin in the Gram-negative heterologous host Escherichia coli BLic5. Additionally, it was experimentally demonstrated that lichenicidin lantibiotics are active against the E. coli imp4213 strain, a mutant strain possessing a permeable outer membrane.
Lichenicidin is a two-component lantibiotic consisting of the peptides Bli␣ and Bli␤, produced by Bacillus licheniformis, with activity against several clinical important Gram-positive strains such as methicillin-resistant Staphylococcus aureus (MRSA). All the machinery involved in the expression, modification, transport, and regulation of the two peptides Bli␣ and Bli␤ are encoded in 14 contiguous open reading frames (ORFs; lic gene cluster) on the B. licheniformis chromosome. Recently, the lic gene cluster was cloned and successfully expressed in Escherichia coli (BLic5 strain). This constituted the first report of fully active lantibiotic production totally in vivo by a Gramnegative host (3) . This expression system was further exploited to investigate the role of all the ORFs of the lic gene cluster through the deletion of each of the genes, except those putatively involved in immunity. Lantibiotic self-protection mechanisms of the producer strain usually involve an individual immunity protein (LanI) and/or an ABC transporter, usually composed of two or three subunits (LanFE[G]). Also, an ancillary protein for the assembly of a functioning ABC transporter has been described (LanH) (5) . These five proteins are putatively represented in the lic gene cluster by the licFGEHI genes (9, 13) . Herein, the role of the five ORFs in lichenicidin self-protection and production by E. coli BLic5 was investigated. Lichenicidin peptides interact synergistically at a ratio of 1:1 within the nanomolar concentration range to exert their full activity (11) . Individually, the action of each peptide requires much higher concentrations (11) . Thus, the replacement of the licFGEHI ORFs by an apramycin resistance cassette was performed in the pLic5 fosmid (containing the complete lichenicidin gene cluster) in which either licA1 or licA2 structural genes were deleted (pLic5⌬A1 and pLic5⌬A2, respectively) to reduce the possibility of bacterial self-killing by the lichenicidin peptides. For this purpose, the Red redirect system was used as previously described by Caetano et al. (3) . The constructed fosmids pLic5⌬A1⌬FGEHI and pLic5⌬A2⌬FGEHI conferring resistance to chloramphenicol (12.5 g/ml) and apramycin (50 g/ml) were transformed into chemically competent E. coli BL21-Gold (DE3) (Agilent). The obtained strains, E. coli BLic5⌬A1⌬FGEHI and E. coli BLic5⌬A2⌬FGEHI (Table 1) , were characterized by the absence of bioactivity against the indicator strain Micrococcus luteus ATCC 9341 (Fig. 1) . These mutants were subjected to cross-feeding agar diffusion experiments, either with Bli␣ (through the strain BLic5⌬A2) or Bli␤ (through the strain BLic5⌬A1) as previously described by Caetano et al. (3) . Bioactivity was completely restored, confirming that E. coli BLic5⌬A1⌬FGEHI retained the capacity to produce Bli␤ and that E. coli BLic5⌬A2⌬FGEHI retained the capacity to produce Bli␣ (Fig. 2) . Likewise, such results were further confirmed by liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS) analysis of butanol extracts ( Fig. 1) as described in Caetano et al. (3) . In order to understand if survival of these mutants retaining biosynthetic capabilities for one of the two peptides was due to the absence of the complementary peptide, Bli␣ or Bli␤, deletion of licFGEHI genes was performed in the pLic5 fosmid possessing both the licA1 and licA2 structural genes. The resulting plasmid, pLic5⌬FGEHI, was constructed and transformed in E. coli as described above. Remarkably, E. coli BLic5⌬FGEHI mutants producing both the Bli␣ and Bli␤ peptides were obtained, as confirmed by bioassay ( Fig. 1 ) and LC-ESI-MS analysis (Fig.  1 ). The relative abundance of both peptides was further investigated by LC-ESI-MS analysis of butanol extracts of three independent cultures of E. coli BLic5 and BLic5⌬FGEHI after 24 h of growth. The values obtained from the TIC (total ion current) peak integration of each peptide were generally higher for BLic5 cultures (Bli␣, 585.7 Ϯ 64.0 arbitrary units [AU]; Bli␤, 236.0 Ϯ 16.6 AU) than for BLic5⌬FGEHI cultures (Bli␣, 400.7 Ϯ 169.5 AU; Bli␤, 125.7 Ϯ 41.8 AU). These results demonstrate undoubtedly that E. coli is able to produce both the Bli␣ and Bli␤ peptides, even if the immunity genes licF-GEHI are not present. Nevertheless, it is not clear if such genetic modification can negatively affect BLic5⌬FGEHI bacterial fitness and consequently the lichenicidin production. The susceptibility of the BLic5 and BLic5⌬FGEHI strains to lichenicidin was also investigated. The agar plates containing each of these strains were prepared as done previously for those used for the bioassays of M. luteus (3) . The lichenicidin sample was obtained from butanol extraction of a BLic5 cul-ture grown for 24 h. The pellet obtained after butanol evaporation was dissolved in aqueous acetonitrile (70%) solution and used in the bioactivity test. After an overnight incubation at 37°C, no inhibition zones were observed on BLic5 and BLic5⌬FGEHI strain plates, suggesting again that licFGEHI are not essential for the lichenicidin self-protection mechanism in Gram-negative E. coli.
In analogy with the mechanism of action of haloduracin and lacticin 3147 reported previously (8, 14) , it is believed that lichenicidin exerts its activity by inhibiting the cell wall biosynthesis accompanied by pore formation in the cytoplasmic membrane. Lantibiotics such as nisin are generally not active against Gram-negative bacteria. It has been shown that this is due to the presence of the outer membrane (OM), since the alteration of its permeability by chelators or some physical treatments resulted in nisin sensitivity by several Gram negatives (1, 6, 12) . Likewise, an E. coli strain with a permeable OM should be sensitive to the extracellular presence of a mixture of Bli␣ and Bli␤ peptides. To prove this hypothesis, a culture of E. coli BLic5 in medium M (3) was performed, and its cell-free supernatant (containing both Bli␣ and Bli␤) was bioassayed against the E. coli imp4213 strain and also its wild-type strain E. coli . The E. coli imp4213 strain possesses a mutation on the essential lptD (imp) gene, which causes an OM permeability defect (2) and thus sensitivity to a variety of antibiotics, including vancomycin, which is otherwise not active against Gram-negative strains (10, 15 ). An inhibition zone caused by the BLic5 supernatant was observed on the agar plates containing the imp4213 strain, contrary to what was registered in the plates inoculated with the wild-type MC4100 strain, where no inhibition of growth was observed (Fig. 3) . The activity of the individual peptides on these two strains was also examined.
To that end, E. coli BLic5⌬A1 (producing exclusively Bli␤) and E. coli BLic5⌬A2 (producing exclusively Bli␣) cell-free supernatants were bioassayed side by side on plates containing either the E. coli imp4213 strain or the E. coli MC4100 strain. It was observed that E. coli imp4213 strain growth was affected only if both Bli␣ and Bli␤ peptides were present (Fig. 3) . These findings proved that in fact, similarly to nisin, once both the Bli␣ and Bli␤ peptides reach the E. coli periplasmic space, they could exert their activity. It was recently demonstrated that the TolC OM protein is related with the presence of the active lichenicidin peptides in the E. coli BLic5 supernatant (3). However, it was not determined whether their transport should involve a periplasmic sublocation. Together, our results suggest that either the peptides are exported through a type I system or at least one of the lichenicidin peptides needs to be inactive in the periplasmic space. In this case, the cooccurrence of Bli␣ and untrimmed Bli␤Ј can be considered, where Bli␤Ј would require extracellular processing by the LicP protease to achieve its Bli␤ active form (3). The fact that it was possible to transform a tolC-deficient E. coli BW25113 with the pLic5⌬FGEHI fosmid (BW⌬tolCLic5⌬FGEHI strain) ( Table  1 ) also supports this hypothesis. After the bioassay, BW⌬tolCLic5⌬FGEHI was not able to inhibit M. luteus growth, in contrast with the control strain (BWLic5⌬FGEHI). Currently, little information is available concerning the lantibiotics' immunity systems. Nevertheless, for lacticin 3147, it was demonstrated that LtnI is an essential protein for the Lactococcus lactis immune phenotype most probably by preventing the insertion of the bacteriocins in the membrane or by interacting directly with the peptides, inactivating them (7). More recently, it was shown that both components of the ABC transporter, LtnFE, are also involved in lacticin 3147 selfprotection. In this case, LtnFE should be involved in the transport of Ltn␣ and Ltn␤ peptides that have crossed the cell wall of the Gram-positive producer (4) . The application of such models to the E. coli lichenicidin expression system could help to explain the results herein reported. If Bli␣ and Bli␤ are not exported simultaneously through the periplasmic space and once outside the cell, the peptides are unable to enter the cell, then at least the LicFEI proteins would be dispensable in such a system. Therefore, BLic5 and BLic5⌬FGEHI lichenicidin self-protection is more likely due to the Gram-negative cell wall structure rather than to the expression of licFGEHI immunity genes. 
